Answers are grounded in this paper and cite their sources.
Clinical wound dressings are often limited by poor wet-tissue adhesion and insufficient microenvironmental responsiveness. To overcome these challenges, we developed a smart chitosan-based hydrogel featuring a dual-network architecture. The hydrogel comprises phenylboronic acid-grafted, methacrylated carboxymethyl chitosan covalently incorporated into a poly(acrylic acid-co-hydroxysuccinimide ester) network through photoinitiated copolymerization of the chitosan methacrylate groups with acrylic acid and N-hydroxysuccinimide (NHS)-functionalized acrylate monomers, with epigallocatechin gallate (EGCG) loaded via dynamic boronate ester bonds. The NHS ester groups enable rapid covalent bonding to tissue amines, ensuring robust adhesion to moist wound beds. The phenylboronic acid moieties bind EGCG through dynamic boronate esters, enabling pH-triggered release in the acidic inflammatory microenvironment. The resulting CMP/PAA-NHS@EGCG hydrogel exhibits outstanding mechanical properties with elongation exceeding 700% and adhesive strength near 38 kPa, and high burst pressure resistance. In vitro studies confirm excellent cytocompatibility, broad-spectrum antibacterial activity, and controlled EGCG release. In vivo evaluation in rat full-thickness wound models demonstrates significantly accelerated healing, characterized by rapid hemostasis, efficient re-epithelialization, and well-organized collagen deposition. By synergistically combining durable physical sealing with on-demand bioactivity, this dual-network platform offers a highly translatable strategy for advanced wound care.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: